this dangerous bill is a legislative Trojan Horse that uses a promising veneer to hide dangerous realities. I do not have the time to go into all of the reasons why I personally am opposing this legislation, but I want to remind my colleagues that a number of patient advocate organizations dedicated to the health and well-being of our constituents, including the ALS Association, the National Alliance for the Mentally Ill, and the Friends of Cancer Research, and this long list here, and so many others that will not fit on this chart, are joining me in my opposition tonight. They, they consider the issue safety. They consider the issue safety. Also, the bill, in addition to the devastating impact on patient safety, would adversely affect the ability of our research-driven pharmaceutical and biotechnology industries to develop breakthrough cures for a myriad of devastating diseases. Many of the solutions to high pharmaceutical prices have already been considered on this floor. They include a meaningful Medicare prescription drug benefit and Hatch-Waxman reforms to ensure quicker access to less costly generic drugs. We also need to find a way to reduce the number of Americans without health insurance. In fact, I recently introduced a bill that would attempt to do just that. Mr. Speaker, this is a bad bill. It will do more harm than good. I urge my colleagues to do the responsible, the responsible and not the political thing, and that is to defeat H.R. 2427 tonight.
Gus Bilirakis: “this dangerous bill is a legislative Trojan Horse that uses a promising veneer to hide dangerous realities. I do not…”
Editor's note · Context
Opposing H.R. 2427 and discussing its implications for patient safety and pharmaceutical innovation.
Share
More from Gus Bilirakis
In closing, I again encourage a ``yes'' vote on this particular piece of legislation. Mr. Speaker, I yield back the balance of my time. The SPEAKER pro tempore. The question is on the motion offered by the gentleman from Florida (Mr…
Mr. Speaker, there is no cost. There is no cost to this particular bill, and it is necessary. Mr. Speaker, the bottom line is that you cannot put a price on the value of life. As a matter of fact, no one should determine a person's quality…
We are learning from those experiences, because a law that gets struck down in court does not protect a child.
I thank Chairman Latta and Ranking Member Matsui for this very important, vital bill. Mr. Speaker, I encourage a ``yes'' vote on this particular bill, and I yield back the balance of my time. The SPEAKER pro tempore. The question is on the…





